Status:

COMPLETED

Improving Pregnancy Outcomes With Progesterone

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

AMAG Pharmaceuticals, Inc.

Conditions:

Pre-term Birth

HIV-1-infection

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

This is a phase III, double-masked, placebo-controlled, randomized controlled trial taking place in Zambia.

Detailed Description

Weekly intramuscular injections of 250mg 17-alpha hydroxyprogesterone caproate (17P) or indistinguishable placebo will be randomly allocated in a 1:1 ratio started between 16-24 weeks gestation and ad...

Eligibility Criteria

Inclusion

  • 18 years of age or older
  • less than 24 0/7 weeks of gestation
  • viable intrauterine singleton pregnancy confirmed by ultrasound
  • antibody-confirmed HIV-1 infection
  • currently receiving antiretroviral l therapy (ART) or intending to commence ART in pregnancy
  • ability and willingness to provide written informed consent
  • intent to remain in current geographical area of residence for the duration of study
  • willing to adhere to weekly study visit schedule

Exclusion

  • confirmed prior spontaneous preterm birth
  • multiple gestation
  • known uterine anomaly
  • planned or in situ cervical cerclage
  • major fetal anomaly detected on screening ultrasound
  • indication for planned delivery prior to 37 weeks (e.g., prior classical cesarean)
  • threatened abortion, preterm labor, or ruptured membranes at time of enrollment
  • known allergy or medical comorbidity listed as a contraindication to 17P in the prescribing information
  • prior participation in the trial
  • any other condition (social or medical) which, in the opinion of the study staff, would make trial participation unsafe or complicate data interpretation.

Key Trial Info

Start Date :

February 7 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 6 2020

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT03297216

Start Date

February 7 2018

End Date

August 6 2020

Last Update

July 22 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kamwala District Clinic

Lusaka, Zambia

2

University Teaching Hospital

Lusaka, Zambia